Research Pipeline
 
Since the end of 2009, the company a total of nine countries 1.1 class new drug application for registration, six of them have obtained the approval documents of clinical.
 
 

Email | Terms of Use | Contact us

2014版权©轩竹医药科技有限公司保留所有权利 鲁ICP备09030169号